Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.
about
Development of an electronic breast pathology database in a community health system.Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy.Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel.An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.A Micro CT Study in Patients with Breast Microcalcifications Using a Mathematical Algorithm to Assess 3D Structure.The significance of lobular neoplasia on needle core biopsy of the breastSentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.B3-lesions of the breast and cancer risk - an analysis of mammography screening patients.Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology.Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients).Pure flat epithelial atypia is uncommon in subsequent breast excisions for atypical epithelial proliferation.Results of Short-Term Follow-Up in BI-RADS 3 and 4a Breast Lesions with a Histological Diagnosis of Fibroadenoma at Percutaneous Needle Biopsy.Can synaptophysin be used as a marker of breast cancer diagnosed by core-needle biopsy in epithelial proliferative diseases of the breast?Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.The fast-track biopsy (FTB): description of a rapid histology and immunohistochemistry method for evaluation of preoperative breast core biopsies
P2860
Q34077507-D37E2336-C2ED-4B16-AA0A-8C6F3A07A340Q35770523-E5AE7898-3F66-4B96-BBE0-8958C9F43ABCQ35862396-279DE738-BF98-4F01-B22D-7BAC5DF81B8BQ36172499-7389643C-F909-499A-9791-AB4965368B67Q36255661-DC2D2645-1C98-48B4-A78E-78D2329C2D3DQ36579505-897D92F4-4AEF-4C2B-B2CF-0E7D46113FC5Q36814404-8B956E31-86D2-40C0-A020-2BE4A72AE787Q36824678-6179CACB-57C6-4966-84EB-9B2AD035027EQ37709576-3521A849-1CEB-41BC-8832-F9304B31EB71Q37740941-A07B0E59-63DB-4A49-A421-D2E41B37EC9FQ42316309-F02CC291-A191-46CB-A5E3-DD4A4D0FBD15Q45074284-E78FE03A-43A8-48E6-BF13-D482B296318AQ47717326-457D9D67-DCAA-4679-9B1F-D534C2BA79DEQ47784499-FC86E510-C479-4783-AD86-E1E78A687F66Q53003561-42D0A226-0231-4E35-B494-8E7C0579D975Q56999735-36C0FED5-333F-4B59-B5FA-403F25727CD5
P2860
Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Best Practice No 179. Guidelin ...... n breast screening assessment.
@ast
Best Practice No 179. Guidelin ...... n breast screening assessment.
@en
type
label
Best Practice No 179. Guidelin ...... n breast screening assessment.
@ast
Best Practice No 179. Guidelin ...... n breast screening assessment.
@en
prefLabel
Best Practice No 179. Guidelin ...... n breast screening assessment.
@ast
Best Practice No 179. Guidelin ...... n breast screening assessment.
@en
P2093
P2860
P356
P1476
Best Practice No 179. Guidelin ...... n breast screening assessment.
@en
P2093
European Commission Working Group on Breast Screening Pathology
H D Zakhour
S Humphreys
UK National Coordinating Commmittee for Breast Screening Pathology
P2860
P304
P356
10.1136/JCP.2003.010983
P407
P577
2004-09-01T00:00:00Z